The Role of Tissue Matrix in the Fracture Resistance of Diabetic Bone

组织基质在糖尿病骨抗骨折中的作用

基本信息

项目摘要

Project Summary The increasing risk of bone fracture with the progression of diabetes is not solely due to reduced bone mineral density (BMD). Since BMD is seemingly normal or even elevated among those with type 2 diabetes, lowering fracture risk among type 2 diabetics requires an understanding of what aspects within the bone tissue matrix contribute to the increase in fracture risk. In addressing this clinically relevant problem, we propose i) to identify pathogenic changes in the bone tissue matrix that contribute to bone fragility as diabetes progresses and ii) to determine how well clinically translatable diagnostic tools (sensitive to the matrix and the mineral of the bone) reflect the diabetes-related changes in fracture resistance. We hypothesize that i) a decrease in the bound water within the bone matrix contributes significantly to the increased fragility of the diabetic bone, ii) a decrease in the matrix bound water is due to diabetes-induced changes in post-translational modifications (PTMs) within bone matrix, and iii) tools capable of measuring bound water in the bone, secondary structure of collagen, and tissue indentation resistance can be used to assess fracture resistance in diabetes. In Aim 1, we will identify molecular differences in PTMs of collagen and osteocalcin between non- diabetic and diabetic bone in mice (model of type 2 diabetes) and in humans (cadaveric tissue from non-insulin dependent diabetics and non-diabetics). Specifically, using liquid chromatography and mass spectrometry, the relative abundance of modifications at individual sites will be quantified for enzyme-mediated hydroxylation and glycosylation of collagen I and carboxylation of osteocalcin and for non-enzymatic PTMs such as carboxymethyllysine and pentosidine, which have been associated with fracture risk. These PTMs potentially affect hydrogen bonding with water and/or the secondary structural organization of collagen. In Aim 2, we will determine whether 1H nuclear magnetic resonance (NMR), Raman spectroscopy (RS), and reference point indentation (RPI) can assess characteristics that differentiate non-diabetic from diabetic bone in mice and in humans. These techniques are chosen for their sensitivity to bound water within bone tissue matrix (NMR), to matrix maturity ratio (RS), and to mechanical consequence of diabetic changes to the matrix and possibly cortical porosity, respectively. Along with areal BMD, micro-computed tomography will be used to quantify volumetric bone and tissue mineral density as well as micro-structure of cortical bone. Mechanical testing will be used to quantify differences in several material properties of bone contributing to the diabetes-related difference in fracture resistance. With correlation analysis and general linear models, we will determine how well RS-, RPI- or NMR-derived values predict the type 2 diabetes-related decrease in the fracture resistance of bone. Moreover, we will determine whether PTMs can explain the possible changes in bound water and matrix maturity ratio in diabetes, thereby providing a potential underlying mechanism.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeffry Stephen Nyman其他文献

Jeffry Stephen Nyman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeffry Stephen Nyman', 18)}}的其他基金

BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Role of Hypertension in Favoring Osteoporosis
BCCMA:针对和抵抗不利于骨骼的条件(骨折遏制)的基础研究:高血压在促进骨质疏松症中的作用
  • 批准号:
    10483572
  • 财政年份:
    2022
  • 资助金额:
    $ 17.38万
  • 项目类别:
Validation of pre-clinical models of musculoskeletal healing following trauma
创伤后肌肉骨骼愈合的临床前模型的验证
  • 批准号:
    10618789
  • 财政年份:
    2021
  • 资助金额:
    $ 17.38万
  • 项目类别:
Validation of pre-clinical models of musculoskeletal healing following trauma
创伤后肌肉骨骼愈合的临床前模型的验证
  • 批准号:
    10392328
  • 财政年份:
    2021
  • 资助金额:
    $ 17.38万
  • 项目类别:
Diabetes-Related Changes Affecting Bone Quality
影响骨质量的糖尿病相关变化
  • 批准号:
    10683072
  • 财政年份:
    2019
  • 资助金额:
    $ 17.38万
  • 项目类别:
Diabetes-Related Changes Affecting Bone Quality
影响骨质量的糖尿病相关变化
  • 批准号:
    9563584
  • 财政年份:
    2019
  • 资助金额:
    $ 17.38万
  • 项目类别:
Diabetes-Related Changes Affecting Bone Quality
影响骨质量的糖尿病相关变化
  • 批准号:
    10436801
  • 财政年份:
    2019
  • 资助金额:
    $ 17.38万
  • 项目类别:
Diabetes-Related Changes Affecting Bone Quality
影响骨质量的糖尿病相关变化
  • 批准号:
    10155432
  • 财政年份:
    2019
  • 资助金额:
    $ 17.38万
  • 项目类别:
Advancing Raman spectroscopy toward the clinical assessment of bone quality
推动拉曼光谱应用于骨质量的临床评估
  • 批准号:
    9752446
  • 财政年份:
    2018
  • 资助金额:
    $ 17.38万
  • 项目类别:
Effects of Sodium-dependent Glucose Co-transporter 2 Inhibition on Bone.
钠依赖性葡萄糖协同转运蛋白 2 抑制对骨的影响。
  • 批准号:
    9193426
  • 财政年份:
    2016
  • 资助金额:
    $ 17.38万
  • 项目类别:
Effects of Sodium-dependent Glucose Co-transporter 2 Inhibition on Bone.
钠依赖性葡萄糖协同转运蛋白 2 抑制对骨的影响。
  • 批准号:
    9304883
  • 财政年份:
    2016
  • 资助金额:
    $ 17.38万
  • 项目类别:

相似海外基金

ADVANCED GLYCOSYLATION END PRODUCTS AND EFFECT OF MESANGIAL CELLS
高级糖基化最终产物和对系膜细胞的影响
  • 批准号:
    3776700
  • 财政年份:
  • 资助金额:
    $ 17.38万
  • 项目类别:
ADVANCED GLYCOSYLATION END PRODUCTS AND EFFECT OF MESANGIAL CELLS
高级糖基化最终产物和对系膜细胞的影响
  • 批准号:
    3840306
  • 财政年份:
  • 资助金额:
    $ 17.38万
  • 项目类别:
ADVANCED GLYCOSYLATION END PRODUCTS AND EFFECT OF MESANGIAL CELLS
高级糖基化最终产物和对系膜细胞的影响
  • 批准号:
    3855332
  • 财政年份:
  • 资助金额:
    $ 17.38万
  • 项目类别:
GLOMERULAR EFFECTS OF ADVANCED GLYCOSYLATION END PRODUCTS
高级糖基化最终产物对肾小球的影响
  • 批准号:
    5202002
  • 财政年份:
  • 资助金额:
    $ 17.38万
  • 项目类别:
GLOMERULAR EFFECTS OF ADVANCED GLYCOSYLATION END PRODUCTS
高级糖基化最终产物对肾小球的影响
  • 批准号:
    3754540
  • 财政年份:
  • 资助金额:
    $ 17.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了